Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.10% Nasdaq Up0.49%

Edwards Lifesciences Corp. (EW)

-NYSE

67.61 Up 0.88(1.32%) 1:46PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 1,899,600   1,678,600   1,447,000  
Cost of Revenue494,600  489,800  408,300  
Gross Profit 1,405,000   1,188,800   1,038,700  
Operating Expenses
Research Development291,300  246,300  204,400  
Selling General and Administrative705,300  642,400  550,000  
Non Recurring16,000  21,600  22,700  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 392,400   278,500   261,600  
Income from Continuing Operations
Total Other Income/Expenses Net3,100  8,200  9,000  
Earnings Before Interest And Taxes395,500  286,700  270,600  
Interest Expense4,400  3,100  2,400  
Income Before Tax391,100  283,600  268,200  
Income Tax Expense97,900  46,900  50,200  
Minority Interest -   -   -  
Net Income From Continuing Ops293,200  236,700  218,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 293,200   236,700   218,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 293,200   236,700   218,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.